CN109567181A - 一类食品原料组合物在解酒方面的应用 - Google Patents
一类食品原料组合物在解酒方面的应用 Download PDFInfo
- Publication number
- CN109567181A CN109567181A CN201811193951.XA CN201811193951A CN109567181A CN 109567181 A CN109567181 A CN 109567181A CN 201811193951 A CN201811193951 A CN 201811193951A CN 109567181 A CN109567181 A CN 109567181A
- Authority
- CN
- China
- Prior art keywords
- alcohol
- parts
- composition
- adenine dinucleotide
- nicotinamide adenine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title claims abstract description 47
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 230000000694 effects Effects 0.000 title claims abstract description 19
- 239000000463 material Substances 0.000 title claims description 4
- 239000000843 powder Substances 0.000 claims abstract description 21
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 11
- 229950006238 nadide Drugs 0.000 claims abstract description 11
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims abstract description 11
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 10
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 10
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 10
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims abstract description 10
- 229940010454 licorice Drugs 0.000 claims abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 9
- 239000008103 glucose Substances 0.000 claims abstract description 9
- 235000013305 food Nutrition 0.000 claims abstract description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 claims abstract 2
- 241000723353 Chrysanthemum Species 0.000 claims description 10
- 210000004185 liver Anatomy 0.000 claims description 5
- 235000009508 confectionery Nutrition 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 229940100688 oral solution Drugs 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000007963 capsule composition Substances 0.000 claims 1
- 235000013402 health food Nutrition 0.000 claims 1
- 230000035622 drinking Effects 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 238000002474 experimental method Methods 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 238000012790 confirmation Methods 0.000 abstract description 3
- 206010025482 malaise Diseases 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 description 33
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 10
- 241000202807 Glycyrrhiza Species 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 3
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 3
- 208000007848 Alcoholism Diseases 0.000 description 3
- 201000007930 alcohol dependence Diseases 0.000 description 3
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 229940053838 glucose 1000 mg Drugs 0.000 description 2
- 235000021552 granulated sugar Nutrition 0.000 description 2
- 230000035987 intoxication Effects 0.000 description 2
- 231100000566 intoxication Toxicity 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 230000036578 sleeping time Effects 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 229940023486 oral product Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 239000011122 softwood Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种解酒的组合物。该组合物包括以下重量份数组份：烟酰胺腺嘌呤二核苷酸0.5‑1份、葡萄糖1‑5份、菊花粉0.25‑2份、甘草粉0.25‑2份。本发明是精心挑选而出的科学有效的组合物，经过合理搭配制成的解酒食品。经药效实验证明，确认能够降低醉倒率，缓解酒后不适症状，促进血液乙醇分解代谢，解酒效果明显。
Description
技术领域
本发明涉及一种用于解酒的组合物。其特征在于，由烟酰胺腺嘌呤二核苷酸(NAD+)、葡萄糖、菊花粉、甘草粉制成，其能够加速人体内酒精(乙醇)代谢，降低血液中乙醇和乙醛的浓度，有利于解酒，缓解酒后不适症状。
技术背景
酒是世界各国人民共同的宝贵财富，酒的历史源远流长，据史学家考证，我国人民饮用和酿造酒类，已有几千年历史了。历代中国文人对酒更是褒赞不绝，形成了独具特色、丰富多彩的酒文化。我国不但酒文化历史源远流长，而且也是酒饮料生产和消费的大国，保守估计有饮酒习惯和依赖性的人群约亿之众。现在我国随着人民物质生活水平的逐渐提高、含酒精乙醇饮料的消耗量也在增加。近年来，成人酒精中毒的发生率也相应升高。众所周知，长期饮酒可造成全身多系统的损伤、尤其对胃肠道，肝脏损伤更为明显，酒精可直接或间接引起慢性胃炎，消化性溃疡和酒精中毒性肝硬化。急性酒精中毒、酒精依赖是当今社会问题之一，无限制的过量饮酒甚至酗酒，严重者可因乙醇过度抑制中枢神经系统而死亡。因此，酗酒对身体有害。很久以来，人们就采用各种方法来解除和减轻饮酒所带来的不适。
现知，酒精在体内的代谢过程主要由肝中的乙醇脱氢酶和乙醛脱氢酶所制约，当酒精被吸收后，进入细胞，由乙醇脱氢酶转化为乙醛。乙醛是一种有毒的化合物，它引起大多与酒精相关的疾病和对酒精产生依赖。乙醛脱氢酶能转化乙醛变成乙酸，乙酸没有毒，很容易被利用为身体提供能量，最后生成水和二氧化碳。然而，无论吸收多少酒精，身体只能在一段时期代谢一定数量的乙醛。因而，酒精吸收经常导致过多的乙醛进入血液循环，对人体器官和功能造成极大的损伤。
为了更好地在传承文化与保护健康之间取得平衡，目前市场上已出现相关的解酒药和解酒保健品，主要依据中医学上的疏经活血、养肝护脾。并且其解酒效果也缺乏客观的验证，在现实生活中消费者对解酒产品的信任度不高。因此，迫切需要开发出具有解酒功效的组合物制成口服制剂，消费者在酒前，酒中或酒后饮用，减少因过量饮酒引起的身体不适。
发明内容
有鉴于此，本发明提供了一种解酒的组合物。该组合物经药效实验证明，确认能够降低醉倒率，缩短醉酒睡眠时间，促进血液乙醇代谢，具有显著的解酒功效。
为了实现上述发明目的，本发明提供以下技术方案：
本发明提供了一种解酒组合物，烟酰胺腺嘌呤二核苷酸0.5-1份、葡萄糖1-5份、菊花粉0.25-2份、甘草粉0.25-2份。
本发明配方NAD+属于人体必需的辅酶，并且人体可以自己合成。葡萄糖，菊花粉、甘草粉，这三个组分都属于传统食材，食用安全。
NAD+是乙醇脱氢酶和乙醛脱氢酶的辅酶，脱氢酶氧化乙醇产生的氢递给NAD+，使之成为NADH。它在糖酵解，糖异生，三羧酸循环和呼吸链中发挥着不可替代的作用。
葡萄糖：迅速补充人体代谢乙醇所消耗的能量，加速乙醇分解。具有高渗压作用，利尿，加速乙醇排出体外。
菊花粉：味道稍苦，清热能力强，常用于散风热。具有疏风散热、养肝明目、清凉解毒的功能，可治伤风感冒、疔疮肿毒、血压偏高及动脉硬化等症。还具有清凉降火，明目醒脑，抗氧化，防衰老的功效。
甘草粉：清热解毒，祛痰，镇咳抗炎，抗过敏，抗癌。
本发明优点：本发明中的组合直接补充人体中所需的NAD+，提高体内NAD+的水平，加速乙醇分解。本发明配方中的原料是科学有效的解酒组合物，依据中国传统中医和西医的两方面理论来设计搭配，经过现代食品工艺的加工，制成本发明解酒组合物。该解酒组合物及经药效实验证明，确认能够降低醉倒率，缩短醉酒睡眠时间，促进血液乙醇代谢，具有显著的解酒功效，效果明显好于单剂。
具体实施方式
实施例1
将烟酰胺腺嘌呤二核苷酸500mg，葡萄糖1000mg，菊花粉350mg，甘草粉350mg经混合，制粒，干燥，压片，制成压片糖果。
实施例2
烟酰胺腺嘌呤二核苷酸800mg，葡萄糖1000mg，菊花粉350mg，甘草粉350mg经混合，加入占总质量50％-60％的微晶纤维素，混合均匀，喷入95％乙醇溶液，制软材，过50目筛制粒，干燥后分装于胶囊中，制得胶囊剂。
实施例3
将烟酰胺腺嘌呤二核苷酸500mg，葡萄糖5g，白砂糖5g，菊花粉2g，甘草粉2g混合均匀，干燥，分装于铝箔袋中，制得固体饮料(凉水或者温水冲调后饮用)。
实施例4
将烟酰胺腺嘌呤二核苷酸500mg，葡萄糖5g，白砂糖5g，菊花粉2g，甘草粉2g经混合，加入常规量的防腐剂，稳定剂等辅料；过滤、灭菌后分装10mL瓶中，制成口服液。
应用实施例1对本发明的解酒效果检测。
1)实验人群：选取100人，年龄25-50岁。
2)服用方法：餐前半小时左右服用，每次1片。
3)效果评定
无效：按要求饮用本产品后，观察本发明产品对饮酒人士的影响，不能缓解醉酒症状，对醉酒状态没有太大影响为无效。
有效：按要求服用本产品后，观察本发明产品对饮酒人士的影响，能缓解醉酒症状，酒量比服用前增加、醉酒后能快速醒来、或精神状态能快速恢复为有效。
显效：按要求服用本产品后，观察本发明产品对饮酒人士的影响，能显著缓解醉酒症状，感觉酒量比服用前明显增加、醉酒后能快速醒来、或精神状态能快速恢复为显效。
| 实验内容 | 总人数 | 显效 | 有效 | 无效 | 总有效率(％) |
| 对醉酒状态影响 | 100 | 90 | 6 | 4 | 96％ |
经过解酒实验证明，口服本发明产品可用于减轻饮酒所致的身体不适症状并且能提高酒量。
Claims (7)
1.一类食品原料组合物其特征在于，由烟酰胺腺嘌呤二核苷酸、葡萄糖、菊花粉、甘草粉等人体可以服用的组分制成。
2.一种用于解酒的组合物。特征在于：包括以下重量份数：烟酰胺腺嘌呤二核苷酸0.5-1份，葡萄糖1-5份，菊花粉0.25-2份，甘草粉0.25-2份。
3.权利要求1中第一项所述化合物与其他任意化合物组合的解酒功能。
4.含有烟酰胺腺嘌呤二核苷酸组分的任何具有保肝护肝功效的组合物。
5.根据权利要求1所述的解酒组合物，其特征在于：所述烟酰胺腺嘌呤二核苷酸含量不大于1g。
6.根据权利要求1-5任意一项所述的解酒组合物和保肝护肝组合物。其特征在于：组合物为口服制剂，包括固体饮料，压片糖果、胶囊剂型糖果、口服液。
7.根据权利要求1-6任意一项所述的解酒组合物的食品和保健食品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811193951.XA CN109567181A (zh) | 2018-10-15 | 2018-10-15 | 一类食品原料组合物在解酒方面的应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811193951.XA CN109567181A (zh) | 2018-10-15 | 2018-10-15 | 一类食品原料组合物在解酒方面的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109567181A true CN109567181A (zh) | 2019-04-05 |
Family
ID=65920031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811193951.XA Pending CN109567181A (zh) | 2018-10-15 | 2018-10-15 | 一类食品原料组合物在解酒方面的应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109567181A (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1706479A (zh) * | 2004-06-08 | 2005-12-14 | 美国酶医公司 | 加速乙醇代谢的方法和组合物 |
| CN101518353A (zh) * | 2008-05-21 | 2009-09-02 | 王建平 | 一种解酒败火护肝饮料及制备方法 |
| CN102038867A (zh) * | 2010-12-31 | 2011-05-04 | 北京迪诺基因科技有限公司 | 一种解酒组合物及其制备方法 |
| CN104640554A (zh) * | 2012-08-03 | 2015-05-20 | 卓越人生有限责任公司 | 用于降低血液酒精含量的组合物和方法 |
| CN105535945A (zh) * | 2016-01-22 | 2016-05-04 | 刘洋 | 一种由生物制剂组成的解酒配方 |
-
2018
- 2018-10-15 CN CN201811193951.XA patent/CN109567181A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1706479A (zh) * | 2004-06-08 | 2005-12-14 | 美国酶医公司 | 加速乙醇代谢的方法和组合物 |
| CN101518353A (zh) * | 2008-05-21 | 2009-09-02 | 王建平 | 一种解酒败火护肝饮料及制备方法 |
| CN102038867A (zh) * | 2010-12-31 | 2011-05-04 | 北京迪诺基因科技有限公司 | 一种解酒组合物及其制备方法 |
| CN104640554A (zh) * | 2012-08-03 | 2015-05-20 | 卓越人生有限责任公司 | 用于降低血液酒精含量的组合物和方法 |
| CN105535945A (zh) * | 2016-01-22 | 2016-05-04 | 刘洋 | 一种由生物制剂组成的解酒配方 |
Non-Patent Citations (3)
| Title |
|---|
| 《保健与生活》杂志社: "《不可不知的安全用药细节》", 31 January 2018, 安徽科学技术出版社 * |
| 祝之友: "《《神农本草经》药物古今临床应用解读》", 31 January 2014, 四川科学技术出版社 * |
| 蒋雁峰: "《中国酒文化研究》", 30 April 2004, 湖南师范大学出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108434231B (zh) | 一种抗醉解酒的药食同源中药组合物及其制备方法 | |
| CN101889679B (zh) | 一种具有解酒保肝作用的组合物及其在食品、保健食品中的应用 | |
| JP5512590B2 (ja) | 二日酔い解消及び予防用組成物とこれを利用した飲酒前後二日酔い解消用飲み物 | |
| CN102934809B (zh) | 益生菌发酵中药制剂制备的组合物及其制备方法和应用 | |
| CN101518353A (zh) | 一种解酒败火护肝饮料及制备方法 | |
| CN102284020A (zh) | 一种具有解酒保肝作用的组合物及其制备方法与应用 | |
| KR102107387B1 (ko) | 흑삼 추출물을 함유하는 숙취해소용 음료 조성물 | |
| CN106562438A (zh) | 一种增强免疫力的组合物及其制备方法 | |
| CN107518133A (zh) | 一种解酒护肝花茶及其制备方法 | |
| CN102038260B (zh) | 中药解酒保健饮料及其制备方法 | |
| CN107693770A (zh) | 一种醒酒护肝组合物 | |
| WO2018077311A1 (zh) | 一种缓解视疲劳的组合物及其制备方法 | |
| CN103191214B (zh) | 一种解酒护肝制剂 | |
| CN105708970B (zh) | 一种具有降血糖功能的保健食品 | |
| CN106563099A (zh) | 一种解酒护肝口服液 | |
| CN105056096B (zh) | 补肾活血通络酒及其制备方法 | |
| CN111297963B (zh) | 一种解酒护肝提取物、组合物及制备方法与应用 | |
| CN105199929B (zh) | 一种健脾补肾保健酒及其制备方法 | |
| CN105613848A (zh) | 醒酒护肝保健茶及其制备方法 | |
| CN105767330A (zh) | 一种保健茶 | |
| CN107397091B (zh) | 一种抗疲劳的苣荬菜运动饮料 | |
| CN109567181A (zh) | 一类食品原料组合物在解酒方面的应用 | |
| CN109846042A (zh) | 一类解酒的食品组合物 | |
| CN106072636A (zh) | 以金花茶为原料的解酒含片及其生产方法 | |
| KR101935861B1 (ko) | 숙취해소 및 간 기능 개선용 건강 기능성 식품 조성물 및 이의 제조 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190405 |
|
| WD01 | Invention patent application deemed withdrawn after publication |